Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
3.13 Up 0.09(2.96%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:3.04
Open:3.07
Bid:1.97 x 200
Ask:3.13 x 10000
1y Target Est:7.00
Beta:2.59
Earnings Date:Aug 10 - Aug 14 (Est.)
Day's Range:3.00 - 3.17
52wk Range:1.94 - 5.48
Volume:1,061,462
Avg Vol (3m):1,960,360
Market Cap:368.95M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRAUp 2.96%368.95M
DVAXDown 1.09%637.05M
PFEDown 0.23%211.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,907.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.45
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback